CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™ into Gynecology
Following Recent FDA Clearance for Cholecystectomy, the Company is now 510(k) pending for Gynecology. This Submission Builds On Extensive Global Clinical Experience in Gynecology and Continues CMR’s U.S. Market Expansion
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
CMR Surgical, the global surgical robotics business, announces that it has received CE and UKCA Marks for its Versius Surgical System (Versius) in paediatric surgery, marking the Company’s first regulatory clearance for treating children. The approval has been received for abdominal surgery in children and infants under the age of 18.
CMR Surgical secures more than $200M to accelerate growth
CMR Surgical, the global surgical robotics company, announces the successful closing of a financing round of over $200 million through a combination of equity and debt capital to support the company’s ambitious growth plans.
Over 30,000 patients treated with Versius
CMR Surgical (CMR) – the global surgical robotics company – announces that more than 30,000 surgical cases have now been completed globally using Versius, solidifying its position as the second most utilised soft-tissue surgical robot on the market.
CMR Surgical appoints Massimiliano Colella as Chief Executive Officer
Massimiliano Colella appointed CEO at CMR Surgical, leading the company in its mission to bring the benefits of robotic-assisted minimal access surgery to patients around the world with Versius
National Robotic Assisted Surgery Programme surpasses the 500-case milestone with Versius
CMR Surgical (CMR) – the global surgical robotics business – has today announced that more than 500 surgical procedures have now been completed using the Versius Surgical Robotic System as part of the All-Wales National Robotic Assisted Surgery Programme.
Leadership change at CMR Surgical
CMR Surgical, the global surgical robotics business, announces the appointment of Massimiliano Colella as Interim Chief Executive Officer as Supratim Bose transitions to Vice-Chairman of the Board.
Milton Keynes University Hospital purchases second Versius system to bring robotic MAS to more patients
CMR Surgical (CMR) – the global surgical robotics business – has today announced that Milton Keynes University Hospital NHS Foundation Trust (MKUH) have installed their second Versius Surgical Robotic System.
CMR Surgical strengthens senior team
CMR Surgical, the global surgical robotics business, announces the appointment of Markus Bauman as Chief Legal & Business Affairs Officer, joining the Company’s executive leadership team.
CMR Surgical ramps up virtual reality offering in world first VR simulator training
Versius® becomes the first soft-tissue surgical robotic system to feature a headset-based virtual reality simulator as part of its metrics-based training pathway
CMR Surgical wins an inaugural King’s Award for Innovation
CMR has been awarded a King’s Award for Enterprise for Innovation for Versius, its small and modular next-generation surgical robotic system. The newly renamed King’s Award for Enterprise celebrates outstanding achievement by UK businesses
Versius has indication extended into thoracic surgery
CMR Surgical (CMR) today announced the Versius Surgical Robotic System® has been indicated for thoracics to support surgeons providing minimally invasive surgery to patients undergoing operations in the lungs, thymus and oesophagus.
CMR Surgical expands into the Middle East
CMR Surgical (CMR) – the global surgical robotics business behind the next-generation surgical robotic system, Versius® – has today announced that it has successfully installed Versius into three hospitals in the United Arab Emirates (UAE), as the Company continues to expand globally in line with its mission to bring the benefits of minimal access surgery to more people around the world.
Versius surgical robot used for first time in an Italian public hospital
CMR Surgical (CMR) – a global surgical robotics business – has announced the introduction of the Versius® Surgical Robotic System, at Policlinico di Milano, a leading research hospital and care institute (IRCCS), and one of the largest healthcare facilities in Lombardy, Italy. Within the hospital, Versius will be used in a multi-specialty robotics programme including thoracic and general surgery.
Versius adopted by Guy’s and St Thomas’ NHS Foundation Trust to improve access to robotic surgery in London
CMR Surgical (CMR) today announced Guy’s and St Thomas’ NHS Foundation Trust as the latest NHS Trust, and first site in London, to adopt the Versius robot.
CMR global footprint grows with regulatory approval for Versius in Brazil
CMR Surgical (CMR) – a global surgical robotics business – announced that it has received regulatory approval for the Versius® Surgical Robotic System from the Brazilian Health Regulatory Agency, Anvisa, paving the way for commercialisation in the high growth Brazilian surgical robotics market.
CMR Surgical builds new global manufacturing facility to meet Versius demand
CMR Surgical (CMR) – a global surgical robotics business – today announced plans to open a new large-scale manufacturing facility in Cambridgeshire, UK. The site will enable upscaled manufacturing processes to meet the increasing global demand for the Versius® Surgical Robotic System, now established as a valuable surgical tool in a number of hospitals across Europe, India, Australia and the…
CMR Surgical strengthens leadership team
CMR Surgical today announces the appointment of Chris Weatherall as Chief Quality and Regulatory Officer (CQRO) and Bertrand Weil as Chief Business Development Officer (CBDO), strengthening the Company’s leadership team as it continues with its global expansion and commercial scale-up.
CMR Surgical’s NHS footprint grows as Gloucestershire Royal Hospital adopts Versius
CMR Surgical (CMR) – a global surgical robotics business – today announced it has extended its NHS footprint as Gloucestershire Royal Hospital has become the latest hospital to adopt Versius. The programme has started with upper GI and will soon be a multi-specialty programme as surgeons across colorectal surgery are trained on the innovative system.
Argenteuil Hospital Center acquires second Versius in less than a year
Argenteuil Hospital Center is the first hospital in Europe to use CMR Surgical's Versius® robot in four surgical specialties – urology, gynaecology, digestive and thoracic.
Versius expands presence in the NHS with installation at East Surrey Hospital
CMR Surgical (CMR) – a global surgical robotics business – today announced the continued expansion of its next-generation surgical robotic system, Versius, within the NHS. For the first time, surgeons at East Surrey Hospital will be using a surgical robot to conduct various multi-specialty procedures, including complex cancer cases.
CMR Surgical raises $600 million in Series D financing
CMR Surgical, a global surgical robotics business, today announces that it has raised $600 million (£425 million) in a Series D financing, the largest ever MedTech private financing round worldwide*.
CMR Surgical becomes the Official Medical Device Partner of ParalympicsGB
Ahead of the Tokyo Games, CMR Surgical has announced it has signed a gold-tier partnership with ParalympicsGB. The sponsorship is set to run for four years over the Tokyo, Beijing and Paris games and will see CMR supporting the team with a campaign to celebrate the power of human ability.
CMR Surgical collaborates with Microsoft in pioneering new trial for health data storage
CMR Surgical (CMR), the global company that has developed the next-generation surgical robot, Versius®, today announced an engagement with Microsoft in a first for health data. Clinical data from Versius procedures was stored onto a small [75x75mm] proof of concept glass platter, which can be safely preserved for more than ten thousand years, as part of the new ‘Project Silica’ trial by Microsoft.
Versius surgical robot begins first gynaecological procedures in NHS hospital
CMR Surgical (CMR) – a global surgical robotics business – has announced the expanded use of its next-generation surgical robotic system Versius® in Europe. For the first time, Versius is being used to conduct major gynaecological procedures, including complex cancer cases, in the NHS at Milton Keynes University Hospital NHS Trust.